Ensuring Desired Target Exposure in the Cochlea with Novel Sustained Release Drug Formulations for Reduced Injection Frequency & Improved Patient Compliance
Time: 1:30 pm
day: Conference Day 2
Details:
- Utilizing targeted delivery systems such as nanoparticle-based carriers and intra-tympanic injections for localized delivery to ensure minimal systemic exposure and maximum therapeutic efficacy
- Developing slow-release drug formulations to improve their ability to penetrate barriers within the inner ear, ensuring optimal target exposure
- Optimizing drug dosage to achieve desired target exposure levels by utilizing pharmacokinetic modelling techniques to improve prediction of drug distribution patterns
